From Regional Patient Advocate Michal Rutkowski
Great news from Lithuania regarding access to modern HAE therapies: As of 1 January 2023, icatibant is reimbursed for Lithuanian HAE patients, and as of 1 March 2023, lanadelumab is also reimbursed for people in Lithuania suffering from HAE.
HAE International is a global non-profit network of member organizations dedicated to raising awareness of hereditary angioedema and improving the lives of people with HAE.
HAE International (HAEi)
10560 Main Street, Ste PS40
Fairfax City, VA 22030
United States of America
gro.ieah@ofni
HAE International (HAEi)
Vejlevej 16, 1.
8700 Horsens
Denmark
gro.ieah@ofni